In The News

  • Email
  • Print
  • Share
  • Text
Highlight Glossary Terms

News tagged ‘ProstateCancer’ clear

  • Several studies published in Nature have identified 74 new genetic risk factors associated with three major cancers: breast, ovarian, and prostate. Dr. Philip Kantoff said it is unclear what this means for patients clinically, but the hope is that it will lead to more sophisticated screening and treatment strategies.

Tags: BasicResearch, BreastCancer, OvarianCancer, ProstateCancer, Genetics, GynecologicCancers

  • Dr. Gabriel Brooks commented on a new study showing Medicare spending for patients with advanced cancer is not linked to differences in survival.

Tags: BreastCancer, ColonCancer, LungCancer, PancreaticCancer, ProstateCancer, Survivorship

  • A study by Dr. Paul Nguyen and colleagues at Dana-Farber/Brigham and Women's Cancer Center shows a small percentage of prostate cancer patients complained their penis seemed shorter following treatment, causing them to regret their choice of treatment.

Tags: ProstateCancer, PopulationScience

  • Dr. Paul Nguyen and colleagues at Dana-Farber/Brigham and Women's Cancer Center report in a study that a small percentage of prostate cancer patients complained that their penis seemed shorter following treatment, causing them to regret the type of treatment they chose.

Tags: ProstateCancer, PopulationScience

  • Dr. Paul Nguyen and colleagues at Dana-Farber/Brigham and Women's Cancer Center report in a study that a small percentage of prostate cancer patients complained that their penis seemed shorter following treatment, causing them to regret the type of treatment they chose.

Tags: ProstateCancer, PopulationScience

  • The recent approval of new drugs for treating advanced prostate cancer provides patients with more clinical choices. Dr. Philip Kantoff, Dana-Farber's Chief Clinical Research Officer, said these options pose challenges to clinicians, who must select the right therapies at the right time for each patient.

Tags: ProstateCancer

  • A study led by Dr. Mary Ellen Taplin that looked at small group of men with prostate cancer showed that treatment with Zytiga eliminated or greatly reduced the size of prostate tumors in one-third of patients treated for six months before surgery.

Tags: ProstateCancer

Showing 1-7 of 7 items